4 research outputs found

    A noninvasive multi-analyte diagnostic assay: Combining protein and DNA markers to stratify bladder cancer patients

    Get PDF
    Purpose: The authors recently reported the development of a noninvasive diagnostic assay using urinary matrix metalloproteinases (MMPs) as monitors of disease-free status and bladder cancer in high-risk populations. Using an approach called clinical intervention determining diagnostic (CIDD), they identified with high confidence those patients who could be excluded from additional intervention. To maximize performance, MMPs were combined with DNAbased markers and CIDD was applied to a population of patients undergoing monitoring for recurrence. Patients and methods: Urine samples were obtained from 323 patients, 48 of whom had a recurrence and 275 of whom did not have cancer upon cytoscopic evaluation. Twist1 and Nid2 methylation status was determined using methylation-specific polymerase chain reaction, FGFR3 mutational status by quantitative PCR, and MMP levels by enzyme-linked immunosorbent assay. Results: Using a combination of these DNA and protein markers, the authors identified with high confidence (97% negative predicted value) those patients who do not have cancer. Cutoffs were adjusted such that at 92% sensitivity, 51% of disease-free patients might be triaged from receiving further tests. Conclusion: The multi-analyte diagnostic readout assay described here is the first to combine protein and DNA biomarkers into one assay for optimal clinical performance. Using this approach, the detection of FGFR3 mutations and Twist1 and Nid2 methylation in the urine of patients undergoing bladder cancer recurrence screening increase the sensitivity and negative predictive value at an established MMP protein cutoff. This noninvasive urinary diagnostic assay could lead to the more efficient triage of patients undergoing recurrence monitoring

    Study of the leptonic decays of the ZO Boson

    Get PDF
    Measurements are presented of the cross section ratios Rℓ = σℓ(e+e-→ℓ+ℓ -)/σhh(e+e-→hadrons) for ℓ = e, μ and τ using data taken from a scan around the Z0. The results are Re = (5.09±0.32±0.18)%, Rμ = (4.96±0.35±0.17)% and Rτ,=(4.72±0.38± 0.29)% where, for the ratio Re, the t-channel contribution has been subtracted. These results are consistent with the hypothesis of lepton universality and test this hypothesis at the energy scale s ∼ 8300 GeV2. The absolute cross sections σℓ(e+e-→ℓ +ℓ-) have also been measured. From the cross sections the leptonic partial widths Γe = (83.2±3.0±2.4) MeV, (ΓeΓμ) 1/2=(84.6±3.0±2.4) MeV and (ΓeΓτ) 1/2=(82.6±3.3±3.2) MeV have been extracted. Assuming lepton universality the ratio Γℓ/Γh=(4.89±0.20± 0.12) × 10-2 was obtained, together with Γℓ=(83.6±1.8±2.2) MeV. The number of light neutrino species is determined to be Nv=3.12±0.24±0.25. Al the data are consistent with the predictions of the standard model.0SCOPUS: ar.jinfo:eu-repo/semantics/publishe

    New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus

    No full text
    corecore